Project Grant R03DK147765
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Colorado-Denver $756,480 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 5, 2025, for a project extending through June 30, 2030. This Project Grant supports research addressing critical evidence gaps in type 2 diabetes management by integrating real-world data from diverse patient populations with data from...
- Federal Grant Award Summary Colorado State University received a $183,540 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026 through March 31, 2031. The award supports the development of a just-in-time adaptive intervention (JITAI) utilizing mobile health technology to promote physical activity in adolescents with type 2 diabetes....
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Colorado-Denver $224,088 through the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on June 11, 2025, with completion targeted for December 31, 2025. This mentored F32 postdoctoral fellowship supports research investigating the physiological regulation of energy intake at meals following weight loss, with Dr. Ezpeleta as...
- Federal Grant Award Summary The University of Colorado-Denver received a $797,416 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026 through March 31, 2029. The award funds research investigating the immunogenetic mechanisms underlying Type 1 Diabetes (T1D) etiology and pathogenesis, with a focus on how genetic variability in natural...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Tufts University School of Medicine a Project Grant of $838,493 on April 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research is being conducted in Dallas, Texas, with a completion date of February 28, 2031. The project, titled "Optimizing Interventions to Improve Nutrition Security and Reduce Diabetes Risk Among...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $129,619 to the University of Colorado-Denver on September 1, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This Project Grant funds investigator-initiated biomedical research examining the interactions between the gut microbiome, intestinal development, and metabolic health outcomes following fetal growth restriction...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $551,250 Project Grant to The Regents of the University of Colorado on February 19, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This three-year award, with completion targeted for January 31, 2029, supports fundamental research into vesicle fusion regulation in metabolic pathways. The research focuses on elucidating...
- Federal Project Grant Award Summary New York University received a $1.94M Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 19, 2025, through August 31, 2028. The award funds research to develop and evaluate an Adaptive Dietary Intervention (ADI) leveraging Continuous Glucose Monitoring (CGM) technology for Asian Americans with Type...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Project Grant of $248,975.00 to The Regents of the University of Colorado-Denver under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for research activities spanning from May 15, 2026, through April 30, 2029. The funded research investigates pancreatic beta-cell glucose toxicity and its relationship to messenger RNA (mRNA) translation, with...
- Grant Award Summary The University of Colorado-Denver received a $234,000 Project Grant awarded on September 15, 2025, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This two-year award, concluding September 14, 2027, supports investigator-initiated biomedical research aimed at elucidating the role of AIOLOS in T cell-mediated pathogenesis of inflammatory bowel disease...
Colorado State University received a $119,536 Project Grant (R03) award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 6, 2026, with completion targeted for April 30, 2028. The award supports implementation science research that systematically identifies contextual determinants affecting the delivery of "What Can I Eat?" (WCIE), a tailored, five-session group-based diabetes nutrition education curriculum designed specifically for American Indian and Alaska Native (AI/AN) populations with Type 2 Diabetes. The research applies the Consolidated Framework for Implementation Research (CFIR 2.0) methodology to address documented implementation barriers, including staffing, scheduling, and resource limitations that currently impede fidelity in program delivery across the 50+ AI/AN-serving organizations where WCIE has been disseminated. Through this award, the research team will conduct semi-structured interviews with 40-60 key informants from AI/AN-serving healthcare and community-based organizations to co-develop feasible implementation strategies. This research enhances an ongoing randomized controlled trial evaluation and directly addresses the critical gap between WCIE's demonstrated effectiveness and its real-world implementation challenges. The work supports NIDDK's programmatic objectives to improve prevention, diagnosis, and treatment of diabetes through evidence-based approaches tailored to health disparities affecting underserved populations.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $119.5k | 5/6/26 |